ASCO: Cullinan, Taiho unveil lung cancer data behind FDA application plans

Earlier this year, Cullinan said its lead candidate hit the bull's-eye in a midstage lung cancer cancer trial but stayed mum on the details. Now, the biotech is revealing the results that have prompted the company and partner Taiho Oncology to pursue an accelerated approval.

May 22, 2025 - 22:50
 0
ASCO: Cullinan, Taiho unveil lung cancer data behind FDA application plans
Earlier this year, Cullinan said its lead candidate hit the bull's-eye in a midstage lung cancer cancer trial but stayed mum on the details. Now, the biotech is revealing the results that have prompted the company and partner Taiho Oncology to pursue an accelerated approval.